Knockdown of CoREST1 decreased tumor cell-mediated stimulation of endothelial cells <i>in vitro</i>. by Sohini Mazumdar (707540)

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…The appreciable mobility of transition metal ions is unexpected, but illustrates the relative energy scales of different defects in the ThCr₂Si₂ structure type. Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…The appreciable mobility of transition metal ions is unexpected, but illustrates the relative energy scales of different defects in the ThCr₂Si₂ structure type. Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…The appreciable mobility of transition metal ions is unexpected, but illustrates the relative energy scales of different defects in the ThCr₂Si₂ structure type. Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…The appreciable mobility of transition metal ions is unexpected, but illustrates the relative energy scales of different defects in the ThCr₂Si₂ structure type. Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

LBM-based approach using synchronous transformation with a time step of 0.43s, PNGM-based method using asynchronous transformation with a 5s time step, VGA using explicit scheme wi... by Mouad Klai (20818364)

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

“…We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”

<i>Med23</i> deletion causes decreased H3K9me2 occupancy among the promoter of <i>Ccl5</i> and <i>Cxcl10</i>. by Zhichao Wang (3570413)

Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean CRT (μm ± standard deviation) significantly decreased from 504.7 ± 118.2 μm preoperatively to 302.5 ± 60.5 at 1 month, 307.5 ± 64.4 at 3 months, 286.8 ± 49.0 at 6 months, 305.3 ± 79.5 at 12 months, 288.8 ± 79.1 at 24 months, and 295.2 ± 87.4 at 36 months (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Contribution of GIRK2-containing channels to RMP and GABA_B-induced inhibition of NPY neurons. by Youjin Oh (3308670)

“…(B, C) Bar graphs and dots summarize RMP (−47.9 ± 0.9 mV, <i>n</i> = 64, for NPY^G2WT and −44.5 ± 0.7 mV, <i>n</i> = 41, for NPY^G2KO, df = 103, t = 2.556, <i>p</i> = 0.012) (B) and input resistance (2.35 ± 0.11 GΩ, <i>n</i> = 64, for NPY^G2WT and 2.78 ± 0.11 GΩ, <i>n</i> = 41, for NPY^G2KO, df = 103, t = 2.590, <i>p</i> = 0.011) (C) of NPY^G2WT (<i>n</i> = 64, black) and NPY^G2KO (<i>n</i> = 41, red) neurons. …”

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”

Fold decrease in virulence gene expression of <i>Salmonella in vivo</i> and <i>in vitro</i>^a. by Xiaojian Yang (295141)

“…Values were expressed as mean ± standard error. The fold-change of target gene was analyzed using the 2^−ΔΔCt method. …”

Decrease in cell migration and adhesion of MCF10A cells after knockdown of <i>MYO1C</i>. by Kittichate Visuttijai (3204519)

“…A dose-dependent decrease in relative cell index response to MYO1C depletion was observed reaching to a significant value with concentrations of 5 and 10 nM of <i>MYO1C</i>-siRNA at 48 hours post-transfection compared to control cells (mock transfection). …”

Class-specific mean decrease in accuracy (MDA) for directed motion and normal-, anomalous- and confined-diffusion. by Thorsten Wagner (1320081)